IL6 and cardiovascular disorder: Moreover, IL-6 together with TNF-α is considered a mediator of systemic COPD effects (cachexia, skeletal muscle dysfunction, cardiovascular diseases, depression, hypodynamia, and osteoporosis), leading to an unfavorable outcome [32].